NASS 2019 Annual Meeting

William Walsh, PhD




Consulting: Australian Biotechnology (D), The Foundry (C), Theracell (C); Grants: Spinal Elements (D); Private Investments: CIMTECH (72,000 Shares, 1%); Research Support (Staff and/or materials): Device Technologies (C, Paid directly to institution/employer), Kuros (F, Paid directly to institution/employer), SeaSpine (F, Paid directly to institution/employer), Sirakoss (F, Paid directly to institution/employer); Royalties: SeaSpine (Future Compensation Expected); Scientific Advisory Board: Collagen Solutions (C), Kuros (C); Stock Ownership: Sirakoss (1%).

Sessions :